SBC Medical Group Holdings Incorporated SBC
4.90
0.15
3.16%
as of 25 Sep
- Market cap
- $488.5M
- P/E
- 10.4×
Follow SBC
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 18.69% | 16.42% | 22.25% | 19.10% |
+8 more TTM periods Free account |
|
| 13.58% | 12.13% | 15.77% | 14.02% | ||
ROIC |
30.71% | 26.61% | 29.67% | 26.15% | |
Return on Tangible Assets |
26.03% | 22.23% | 28.70% | 22.85% | |
Average Days of Receivables |
105.90 | 96.13 | 83.64 | 150.59 | |
Free Cash Flow per Share |
0.65 | 0.36 | 0.29 | (0.33) | |
Free Cash Flow |
66.45 | 36.96 | 29.78 | (33.88) | |
Capital Expenditures |
3.63 | 4.99 | 5.11 | 0.72 | |
Piotroski F-Score |
3.00 | 2.00 | 3.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
12.51% | 6.68% | 5.24% | (8.72%) | |
Accounts Receivable Turnover |
3.06 | 3.95 | 4.32 | 2.99 | |
Accounts Payable Turnover |
2.28 | 2.56 | 2.88 | 2.64 | |
Inventory Turnover |
21.05 | 24.61 | 21.61 | 25.24 | |
Average Days of Payables |
175.93 | 145.40 | 138.99 | 158.69 | |
Days of Inventory on Hand |
22.06 | 17.16 | 22.00 | 13.24 | |
Tax Rate |
(0.34) | (0.41) | (0.38) | (0.38) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
34.51% | 34.78% | 34.44% | 32.40% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.28 | 0.78 | 0.48 | (0.80) | |
Depreciation/Fixed assets |
0.43 | 0.37 | 0.36 | 0.42 | |
Capex/Depreciation |
1.13 | 1.83 | 1.90 | 0.25 | |
Revenue per Share |
1.71 | 1.65 | 1.69 | 1.74 | |
Operating CF per Share |
0.61 | 0.31 | 0.24 | (0.34) | |
Capex per Share |
0.04 | 0.05 | 0.05 | 0.01 | |
Capex to Sales |
(0.02) | (0.03) | (0.03) | 0.00 | |
Net Profit Margin |
27.99% | 24.09% | 29.37% | 24.28% |
Columns are period end dates